(Q31729479)

3 July 2017

1 reference

title

Overcoming drug resistance in ovarian carcinoma (English)

1 reference

3 July 2017

1 reference

Fracasso PM

1

1 reference

3 July 2017

publication date

1 January 2001

1 reference

3 July 2017

published in

Current Oncology Reports

1 reference

3 July 2017

volume

3

1 reference

3 July 2017

issue

1

1 reference

3 July 2017

page(s)

19-26

1 reference

Glutathione S-transferase expression in benign and malignant ovarian tumours

3 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-001-0038-Z

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-001-0038-Z

Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-001-0038-Z

The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-001-0038-Z

Expression of P-glycoprotein in epithelial ovarian cancer: evaluation as a marker of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-001-0038-Z

Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.

21 January 2018

1 reference

12 December 2020

Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance

1 reference

12 December 2020

Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies.

1 reference

12 December 2020

Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.

1 reference

12 December 2020

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients

1 reference

12 December 2020

Preclinical and clinical experience with cisplatin resistance

1 reference

12 December 2020

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

12 December 2020

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

1 reference

12 December 2020

Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin

1 reference

12 December 2020

Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines

1 reference

12 December 2020

Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.

1 reference

12 December 2020

Drug resistance in ovarian cancer: from the laboratory to the clinic

1 reference

12 December 2020

P-glycoprotein-mediated multidrug resistance: experimental and clinical strategies for its reversal

1 reference

12 December 2020

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction

1 reference

12 December 2020

Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer.

1 reference

12 December 2020

Intermittent high-dose tamoxifen as a potential modifier of multidrug resistance.

1 reference

12 December 2020

Glutathione S-transferase activity in epithelial ovarian cancer: Association with response to chemotherapy and disease outcome

1 reference

12 December 2020

Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP.

1 reference

12 December 2020

Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line

1 reference

12 December 2020

Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems

1 reference

12 December 2020

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

12 December 2020

Glutathione and related enzymes in multidrug resistance

1 reference

12 December 2020

Multiple drug resistance parameter expression in ovarian cancer.

1 reference

12 December 2020

Clinical studies of reversal of drug resistance based on glutathione

1 reference

12 December 2020

Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death

1 reference

12 December 2020

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

1 reference

12 December 2020

Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study.

1 reference

12 December 2020

Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors

1 reference

12 December 2020

Drug resistance modulation in the laboratory and the clinic.

1 reference

12 December 2020

Mechanisms of drug resistance in ovarian cancer

1 reference

12 December 2020

Cellular and molecular determinants of cisplatin resistance

1 reference

12 December 2020

Immunohistochemical analysis of P-glycoprotein expression in diverse histological types of epithelial ovarian tumors.

1 reference

12 December 2020

Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer

1 reference

12 December 2020

Cancer statistics, 2000.

1 reference

12 December 2020

Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers.

1 reference

12 December 2020

Phase I/pharmacokinetic study of high-dose progesterone and doxorubicin

1 reference

12 December 2020

Clinical reversal of drug resistance in ovarian cancer

1 reference

12 December 2020

Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line

1 reference

12 December 2020

Chemotherapy of advanced ovarian cancer

1 reference

12 December 2020

A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines

1 reference

12 December 2020

Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro

1 reference

12 December 2020

Cisplatin resistance and DNA repair

1 reference

12 December 2020

Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patients

1 reference

12 December 2020

Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas

1 reference

12 December 2020

Expression of a human multidrug resistance gene in ovarian carcinomas.

1 reference

12 December 2020

P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy

1 reference

12 December 2020

Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines

1 reference

12 December 2020

MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors

1 reference

12 December 2020

Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer

1 reference

12 December 2020

Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy

1 reference

12 December 2020

Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance

1 reference

12 December 2020

Chemotherapy resistance in ovarian cancer: new molecular perspectives.

1 reference

12 December 2020

Verapamil with mitoxantrone for advanced ovarian cancer: a negative phase II trial

1 reference

12 December 2020

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

1 reference

12 December 2020

Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446

1 reference

12 December 2020

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

1 reference

12 December 2020

10.1007/S11912-001-0038-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

3 July 2017

1029800112

0 references

1 reference